Cardiac fibroblast transcriptome analyses support a role for interferogenic, profibrotic, and inflammatory genes in anti-SSA/Ro-associated congenital heart block

Am J Physiol Heart Circ Physiol. 2017 Sep 1;313(3):H631-H640. doi: 10.1152/ajpheart.00256.2017. Epub 2017 Jun 16.

Abstract

The signature lesion of SSA/Ro autoantibody-associated congenital heart block (CHB) is fibrosis and a macrophage infiltrate, supporting an experimental focus on cues influencing the fibroblast component. The transcriptomes of human fetal cardiac fibroblasts were analyzed using two complementary approaches. Cardiac injury conditions were simulated in vitro by incubating human fetal cardiac fibroblasts with supernatants from macrophages transfected with the SSA/Ro-associated noncoding Y ssRNA. The top 10 upregulated transcripts in the stimulated fibroblasts reflected a type I interferon (IFN) response [e.g., IFN-induced protein 44-like (IFI44L), of MX dynamin-like GTPase (MX)1, MX2, and radical S-adenosyl methionine domain containing 2 (Rsad2)]. Within the fibrotic pathway, transcript levels of endothelin-1 (EDN1), phosphodiesterase (PDE)4D, chemokine (C-X-C motif) ligand (CXCL)2, and CXCL3 were upregulated, while others, including adenomedullin, RAP guanine nucleotide exchange factor 3 (RAPGEF3), tissue inhibitor of metalloproteinase (TIMP)1, TIMP3, and dual specificity phosphatase 1, were downregulated. Agnostic Database for Annotation, Visualization and Integrated Discovery analysis revealed a significant increase in inflammatory genes, including complement C3A receptor 1 (C3AR1), F2R-like thrombin/trypsin receptor 3, and neutrophil cytosolic factor 2. In addition, stimulated fibroblasts expressed high levels of phospho-MADS box transcription enhancer factor 2 [a substrate of MAPK5 (ERK5)], which was inhibited by BIX-02189, a specific inhibitor of ERK5. Translation to human disease leveraged an unprecedented opportunity to interrogate the transcriptome of fibroblasts freshly isolated and cell sorted without stimulation from a fetal heart with CHB and a matched healthy heart. Consistent with the in vitro data, five IFN response genes were among the top 10 most highly expressed transcripts in CHB fibroblasts. In addition, the expression of matrix-related genes reflected fibrosis. These data support the novel finding that cardiac injury in CHB may occur secondary to abnormal remodeling due in part to upregulation of type 1 IFN response genes.NEW & NOTEWORTHY Congenital heart block is a rare disease of the fetal heart associated with maternal anti-Ro autoantibodies which can result in death and for survivors, lifelong pacing. This study provides in vivo and in vitro transcriptome-support that injury may be mediated by an effect of Type I Interferon on fetal fibroblasts.

Keywords: RNASeq; autoimmune congenital heart block; cardiac fibroblast.

MeSH terms

  • Adult
  • Antibodies, Antinuclear / genetics
  • Antibodies, Antinuclear / immunology
  • Antibodies, Antinuclear / metabolism*
  • Cells, Cultured
  • Culture Media, Conditioned / metabolism
  • Female
  • Fetal Heart / immunology
  • Fetal Heart / metabolism*
  • Fetal Heart / pathology
  • Fibroblasts / metabolism*
  • Fibroblasts / pathology
  • Fibrosis
  • Gene Expression Profiling* / methods
  • Gene Expression Regulation
  • Heart Block / congenital*
  • Heart Block / genetics
  • Heart Block / immunology
  • Heart Block / metabolism
  • Heart Block / pathology
  • Humans
  • Inflammation Mediators / immunology
  • Inflammation Mediators / metabolism*
  • Interferon Regulatory Factors / genetics
  • Interferon Regulatory Factors / metabolism
  • Interferon Type I / immunology
  • Interferon Type I / metabolism*
  • Macrophages / immunology
  • Macrophages / metabolism
  • Myocardium
  • Paracrine Communication
  • Pregnancy
  • Transcriptome*
  • Transfection

Substances

  • Antibodies, Antinuclear
  • Culture Media, Conditioned
  • Inflammation Mediators
  • Interferon Regulatory Factors
  • Interferon Type I
  • SS-A antibodies

Supplementary concepts

  • Congenital heart block